NCT07549789

Brief Summary

This randomized controlled trial aims to evaluate the effect of foot reflexology on comfort levels and physiological parameters in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Neonates in the intervention group will receive standardized foot reflexology sessions in addition to routine care, while the control group will receive routine care alone. Comfort will be assessed using the COMFORTneo scale, and physiological parameters will be monitored throughout the intervention period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 30, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2026

Completed
Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

1.6 years

First QC Date

March 30, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

Foot reflexologytherapeutic hypothermiaHypoxic-Ischemic EncephalopathyComfortNeo

Outcome Measures

Primary Outcomes (1)

  • COMFORTneo score

    COMFORTneo was used to assess pain and distress in neonates. The scale consists of six behavioral items scored from 1 to 5, yielding a total score ranging from 6 to 30. Higher scores indicate greater pain or distress. COMFORTneo assessments were performed at baseline (T0), 24 hours (T1), 48 hours (T2), and 72 hours (T3) by an outcome assessor blinded to group allocation.

    Baseline, 24 hours, 48 hours, and 72 hours

Secondary Outcomes (5)

  • Heart rate

    Immediately before and immediately after one designated session per day for 3 consecutive days

  • Respiratory rate

    Immediately before and immediately after one designated session per day for 3 consecutive days

  • Rectal temperature

    Immediately before and immediately after one designated session per day for 3 consecutive days

  • Mean arterial pressure (MAP)

    Immediately before and immediately after one designated session per day for 3 consecutive days

  • Oxygen saturation (SpO₂)

    Immediately before and immediately after one designated session per day for 3 consecutive days

Study Arms (2)

Foot Reflexology

EXPERIMENTAL

Participants in this arm received standardized foot reflexology in addition to standard care during therapeutic hypothermia. Foot reflexology was administered three times daily at approximately 8-hour intervals for 72 hours. Each session lasted 15 minutes, with equal time allocated to both feet, resulting in a total of nine sessions and a cumulative intervention time of 135 minutes per participant. All sessions were performed by the same trained and certified researcher under continuous clinical monitoring and predefined safety stopping criteria.

Other: Foot reflexology

Standard Care

ACTIVE COMPARATOR

Participants in this arm received standard therapeutic hypothermia and routine neonatal intensive care without any additional tactile intervention or foot reflexology.

Other: Standard care

Interventions

A standardized foot reflexology protocol was administered three times daily at approximately 8-hour intervals for 72 hours. Each session lasted 15 minutes, with equal time allocated to both feet, resulting in nine sessions and a cumulative intervention time of 135 minutes per participant. The intervention targeted four protocol-defined foot areas: the head/brain, solar plexus, spine, and diaphragm zones. Light-to-moderate pressure was applied, while abrupt, forceful, or painful pressure was avoided. No oil, lotion, or warming material was used. All sessions were performed by the same trained and certified researcher under continuous clinical monitoring and predefined safety stopping criteria.

Foot Reflexology

Standard therapeutic hypothermia and routine neonatal intensive care without additional tactile stimulation.

Standard Care

Eligibility Criteria

Age0 Days+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age ≥36 weeks
  • Therapeutic hypothermia initiated within the first 6 hours after birth for hypoxic-ischemic encephalopathy
  • Moderate or severe hypoxic-ischemic encephalopathy according to the modified Sarnat classification
  • Evidence of perinatal hypoxia, including umbilical cord or early postnatal blood gas pH ≤7.00 or base excess ≤-16 mmol/L within the first hour of life, or a 10-minute Apgar score \<5 or ongoing resuscitation
  • Not receiving invasive mechanical ventilation
  • Clinically stable for the intervention as determined by the attending neonatologist
  • Written informed consent obtained from a parent or legal guardian

You may not qualify if:

  • Invasive mechanical ventilation
  • Major congenital anomaly
  • Severe intracranial hemorrhage
  • Multiple organ failure
  • Skin lesion, trauma, or vascular access involving the lower extremities that could interfere with foot reflexology
  • Active resuscitation
  • Severe hemodynamic instability
  • Uncontrolled seizures or neurological deterioration compromising intervention safety
  • Any clinical event or device/airway/vascular access concern preventing safe administration of the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep Anka Hospital

Gaziantep, Gaziantep, 27590, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Alev S Sivaslı, PhD

    istanbul nişantaşı üniversitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor who performed the COMFORTneo assessments was blinded to group allocation. Due to the nature of the intervention, the reflexology provider could not be blinded. Group codes were masked during data analysis.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either the intervention group or the control group using a parallel-group design with a 1:1 allocation ratio. The intervention group will receive standardized foot reflexology in addition to routine neonatal intensive care, while the control group will receive routine care only. The study follows a parallel assignment model in which both groups are observed over the same therapeutic hypothermia period. The intervention is administered repeatedly to evaluate both immediate and cumulative effects on comfort and physiological parameters. Outcome measures are collected at predefined time points across the study period to allow comparison between groups and over time. Blinding will be applied at the level of outcome assessment to minimize bias.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 24, 2026

Study Start

February 3, 2025

Primary Completion

August 27, 2026

Study Completion

August 27, 2026

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available because the study involves sensitive neonatal clinical data and is subject to ethical and privacy restrictions. De-identified data may be made available from the corresponding author upon reasonable request, subject to applicable ethical approval, institutional requirements, and data protection regulations.

Locations